The apparent paucity of vaccine-associated myocarditis cases among the 5-11 age group is really interesting. It also seems clear now, based on data presented to VRBPAC and ACIP (among other sources), that:
- The reaction is most common in males in their late teens and early 20s.
- It does occur following the first dose in a significant number of cases (though far less frequently than following the second).
- It's occurring less frequently with third doses, though that could just be due to selection bias.
- It seems to be somewhat more common with the Moderna vaccine than with the Pfizer vaccine.
I wonder if, taken together, this information can tell us anything about the underlying mechanism of mRNA vaccine-induced myocarditis?
The apparent paucity of vaccine-associated myocarditis cases among the 5-11 age group is really interesting. It also seems clear now, based on data presented to VRBPAC and ACIP (among other sources), that:
- The reaction is most common in males in their late teens and early 20s.
- It does occur following the first dose in a significant number of cases (though far less frequently than following the second).
- It's occurring less frequently with third doses, though that could just be due to selection bias.
- It seems to be somewhat more common with the Moderna vaccine than with the Pfizer vaccine.
I wonder if, taken together, this information can tell us anything about the underlying mechanism of mRNA vaccine-induced myocarditis?